Last 12 months
Inside the activity.
0 purchase rows · 36 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 6 |
| Dec 2025 | 0 | 17 |
| Jan 2026 | 0 | 3 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 5 |
| Jul 2026 | 0 | 3 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 17, 2025 Filed Dec 18, 2025 17:35 UTC |
Tang Carolyn C.General Counsel
|
SaleCommon Stock | 6,810 | $22.16 | $150,906.20 |
DisclosureSEC source: 0001836662-25-000005 · wk-form4_1766097342.xml · nonDerivative · entry 2 Tang Carolyn C. · CIK 0001836662 · General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 124,734 F1 · shares: Represents shares sold by the issuer on the reporting person's behalf to cover tax withholding obligations in connection with the vesting of certain RSUs (previously reported in Table I) following the date of grant. The sale occurred automatically pursuant to the Issuer's equity administration policy, which was implemented on May 22, 2025, and does not represent a discretionary trade by the reporting person. F5 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.92 to $22.42, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F4 · balance_after: Includes the unvested portion of the reporting person's RSU grants. Read SEC document |
| December 17, 2025 Filed Dec 18, 2025 22:35 UTC |
Azoy AlexanderChief Accounting Officer
|
SaleCommon Stock | 2,113 | $22.16 | $46,823.02 |
DisclosureSEC source: 0001771961-25-000014 · wk-form4_1766097326.xml · nonDerivative · entry 2 Azoy Alexander · CIK 0001771961 · Chief Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 22,874 F1 · shares: Represents shares sold by the issuer on the reporting person's behalf to cover tax withholding obligations in connection with the vesting of certain RSUs (previously reported in Table I) following the date of grant. The sale occurred automatically pursuant to the Issuer's equity administration policy, which was implemented on May 22, 2025, and does not represent a discretionary trade by the reporting person. F4 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.92 to $22.42, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F3 · balance_after: Includes the unvested portion of the reporting person's RSU grants. Read SEC document |
| December 17, 2025 Filed Dec 18, 2025 22:35 UTC |
Goeltz II Robert C.Chief Financial Officer
|
SaleCommon Stock | 5,960 | $22.16 | $132,070.62 |
DisclosureSEC source: 0001653881-25-000011 · wk-form4_1766097319.xml · nonDerivative · entry 2 Goeltz II Robert C. · CIK 0001653881 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 74,476 F1 · shares: Represents shares sold by the issuer on the reporting person's behalf to cover tax withholding obligations in connection with the vesting of certain RSUs (previously reported in Table I) following the date of grant. The sale occurred automatically pursuant to the Issuer's equity administration policy, which was implemented on May 22, 2025, and does not represent a discretionary trade by the reporting person. F4 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.92 to $22.42, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F3 · balance_after: Includes the unvested portion of the reporting person's RSU grants. Read SEC document |
| December 17, 2025 Filed Dec 18, 2025 22:35 UTC |
Jarrett JenniferChief Operating Officer
|
SaleCommon Stock | 9,983 | $22.16 | $221,218.29 |
DisclosureSEC source: 0001671311-25-000009 · wk-form4_1766097311.xml · nonDerivative · entry 2 Jarrett Jennifer · CIK 0001671311 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 193,024 F1 · shares: Represents shares sold by the issuer on the reporting person's behalf to cover tax withholding obligations in connection with the vesting of certain RSUs (previously reported in Table I) following the date of grant. The sale occurred automatically pursuant to the Issuer's equity administration policy, which was implemented on May 22, 2025, and does not represent a discretionary trade by the reporting person. F4 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.92 to $22.42, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F3 · balance_after: Includes the unvested portion of the reporting person's RSU grants. Read SEC document |
| December 17, 2025 Filed Dec 18, 2025 22:35 UTC |
Jaen Juan C.President
|
SaleCommon Stock | 9,983 | $22.16 | $221,218.29 |
DisclosureSEC source: 0001422996-25-000015 · wk-form4_1766097305.xml · nonDerivative · entry 2 Jaen Juan C. · CIK 0001422996 · President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 346,012 F1 · shares: Represents shares sold by the issuer on the reporting person's behalf to cover tax withholding obligations in connection with the vesting of certain RSUs (previously reported in Table I) following the date of grant. The sale occurred automatically pursuant to the Issuer's equity administration policy, which was implemented on May 22, 2025, and does not represent a discretionary trade by the reporting person. F4 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.92 to $22.42, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F3 · balance_after: Includes the unvested portion of the reporting person's RSU grants. Read SEC document |
| December 17, 2025 Filed Dec 18, 2025 22:35 UTC |
ROSEN TERRY JDirector · Chief Executive Officer
|
SaleCommon Stock | 25,744 | $22.16 | $570,474.17 |
DisclosureSEC source: 0001182473-25-000005 · wk-form4_1766097299.xml · nonDerivative · entry 2 ROSEN TERRY J · CIK 0001182473 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,194,809 F1 · shares: Represents shares sold by the issuer on the reporting person's behalf to cover tax withholding obligations in connection with the vesting of certain RSUs (previously reported in Table I) following the date of grant. The sale occurred automatically pursuant to the Issuer's equity administration policy, which was implemented on May 22, 2025, and does not represent a discretionary trade by the reporting person. F5 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.92 to $22.42, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F3 · balance_after: Includes 236 shares purchased on November 30, 2025 through the Company's Employee Stock Purchase Plan. F4 · balance_after: Includes the unvested portion of the reporting person's RSU grants. Read SEC document |
| December 16, 2025 Filed Dec 18, 2025 17:35 UTC |
Markus RichardChief Medical Officer
|
SaleCommon Stock | 5,052 | $21.88 | $110,559.48 |
DisclosureSEC source: 0002056093-25-000005 · wk-form4_1766097334.xml · nonDerivative · entry 1 Markus Richard · CIK 0002056093 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 70,141 F1 · shares: Represents shares sold by the issuer on the reporting person's behalf to cover tax withholding obligations in connection with the vesting of certain RSUs (previously reported in Table I) following the date of grant. The sale occurred automatically pursuant to the Issuer's equity administration policy, which was implemented on May 22, 2025, and does not represent a discretionary trade by the reporting person. F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.42 to $22.39, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F3 · balance_after: Includes the unvested portion of the reporting person's RSU grants. Read SEC document |
| December 16, 2025 Filed Dec 18, 2025 17:35 UTC |
Tang Carolyn C.General Counsel
|
SaleCommon Stock | 7,658 | $21.88 | $167,589.97 |
DisclosureSEC source: 0001836662-25-000005 · wk-form4_1766097342.xml · nonDerivative · entry 1 Tang Carolyn C. · CIK 0001836662 · General Counsel 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 131,544 F1 · shares: Represents shares sold by the issuer on the reporting person's behalf to cover tax withholding obligations in connection with the vesting of certain RSUs (previously reported in Table I) following the date of grant. The sale occurred automatically pursuant to the Issuer's equity administration policy, which was implemented on May 22, 2025, and does not represent a discretionary trade by the reporting person. F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.42 to $22.39, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F3 · balance_after: Includes 1 share purchased on November 30, 2025 through the Company's Employee Stock Purchase Plan. F4 · balance_after: Includes the unvested portion of the reporting person's RSU grants. Read SEC document |
| December 16, 2025 Filed Dec 18, 2025 22:35 UTC |
Azoy AlexanderChief Accounting Officer
|
SaleCommon Stock | 2,376 | $21.88 | $51,997.10 |
DisclosureSEC source: 0001771961-25-000014 · wk-form4_1766097326.xml · nonDerivative · entry 1 Azoy Alexander · CIK 0001771961 · Chief Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 24,987 F1 · shares: Represents shares sold by the issuer on the reporting person's behalf to cover tax withholding obligations in connection with the vesting of certain RSUs (previously reported in Table I) following the date of grant. The sale occurred automatically pursuant to the Issuer's equity administration policy, which was implemented on May 22, 2025, and does not represent a discretionary trade by the reporting person. F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.42 to $22.39, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F3 · balance_after: Includes the unvested portion of the reporting person's RSU grants. Read SEC document |
| December 16, 2025 Filed Dec 18, 2025 22:35 UTC |
Goeltz II Robert C.Chief Financial Officer
|
SaleCommon Stock | 6,702 | $21.88 | $146,668.58 |
DisclosureSEC source: 0001653881-25-000011 · wk-form4_1766097319.xml · nonDerivative · entry 1 Goeltz II Robert C. · CIK 0001653881 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 80,436 F1 · shares: Represents shares sold by the issuer on the reporting person's behalf to cover tax withholding obligations in connection with the vesting of certain RSUs (previously reported in Table I) following the date of grant. The sale occurred automatically pursuant to the Issuer's equity administration policy, which was implemented on May 22, 2025, and does not represent a discretionary trade by the reporting person. F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.42 to $22.39, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F3 · balance_after: Includes the unvested portion of the reporting person's RSU grants. Read SEC document |
| December 16, 2025 Filed Dec 18, 2025 22:35 UTC |
Jarrett JenniferChief Operating Officer
|
SaleCommon Stock | 11,225 | $21.88 | $245,651.27 |
DisclosureSEC source: 0001671311-25-000009 · wk-form4_1766097311.xml · nonDerivative · entry 1 Jarrett Jennifer · CIK 0001671311 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 203,007 F1 · shares: Represents shares sold by the issuer on the reporting person's behalf to cover tax withholding obligations in connection with the vesting of certain RSUs (previously reported in Table I) following the date of grant. The sale occurred automatically pursuant to the Issuer's equity administration policy, which was implemented on May 22, 2025, and does not represent a discretionary trade by the reporting person. F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.42 to $22.39, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F3 · balance_after: Includes the unvested portion of the reporting person's RSU grants. Read SEC document |
| December 16, 2025 Filed Dec 18, 2025 22:35 UTC |
Jaen Juan C.President
|
SaleCommon Stock | 11,225 | $21.88 | $245,651.27 |
DisclosureSEC source: 0001422996-25-000015 · wk-form4_1766097305.xml · nonDerivative · entry 1 Jaen Juan C. · CIK 0001422996 · President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 355,995 F1 · shares: Represents shares sold by the issuer on the reporting person's behalf to cover tax withholding obligations in connection with the vesting of certain RSUs (previously reported in Table I) following the date of grant. The sale occurred automatically pursuant to the Issuer's equity administration policy, which was implemented on May 22, 2025, and does not represent a discretionary trade by the reporting person. F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.42 to $22.39, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F3 · balance_after: Includes the unvested portion of the reporting person's RSU grants. Read SEC document |
| December 16, 2025 Filed Dec 18, 2025 22:35 UTC |
ROSEN TERRY JDirector · Chief Executive Officer
|
SaleCommon Stock | 28,947 | $21.88 | $633,484.83 |
DisclosureSEC source: 0001182473-25-000005 · wk-form4_1766097299.xml · nonDerivative · entry 1 ROSEN TERRY J · CIK 0001182473 · Director · Chief Executive Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,220,553 F1 · shares: Represents shares sold by the issuer on the reporting person's behalf to cover tax withholding obligations in connection with the vesting of certain RSUs (previously reported in Table I) following the date of grant. The sale occurred automatically pursuant to the Issuer's equity administration policy, which was implemented on May 22, 2025, and does not represent a discretionary trade by the reporting person. F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.42 to $22.39, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F3 · balance_after: Includes 236 shares purchased on November 30, 2025 through the Company's Employee Stock Purchase Plan. F4 · balance_after: Includes the unvested portion of the reporting person's RSU grants. Read SEC document |
| December 16, 2025 Filed May 12, 2026 20:09 UTC |
Ribas AntoniDirector
|
GiftCommon Stock | 5,050 | $0.00 | $0.00 |
DisclosureSEC source: 0001792164-26-000003 · wk-form4_1778616552.xml · nonDerivative · entry 1 Ribas Antoni · CIK 0001792164 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,600 F1 · shares: Gift to family members for estate planning purposes. F2 · balance_after: Includes the unvested portion of the reporting person's RSU grants. Read SEC document |
| December 04, 2025 Filed Dec 5, 2025 21:15 UTC |
Jaen Juan C.President
|
SaleCommon Stock | 82,997 | $24.71 | $2,050,598.58 |
DisclosureSEC source: 0001422996-25-000011 · wk-form4_1764969323.xml · nonDerivative · entry 1 Jaen Juan C. · CIK 0001422996 · President 10b5-1 filing: Plan reported Ownership: Indirect · By Trust Disclosed balance after: 954,063 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 8, 2025. F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.35 to $25.15, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| November 26, 2025 Filed Nov 26, 2025 21:07 UTC |
Goeltz II Robert C.Chief Financial Officer
|
SaleCommon Stock | 5,000 | $25.00 | $125,000.00 |
DisclosureSEC source: 0001653881-25-000007 · wk-form4_1764191259.xml · nonDerivative · entry 1 Goeltz II Robert C. · CIK 0001653881 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 87,138 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| November 26, 2025 Filed Dec 1, 2025 23:09 UTC |
Azoy AlexanderChief Accounting Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 1,900 | $0.00 Strike: $13.33 | $0.00 |
DisclosureSEC source: 0001771961-25-000009 · wk-form4_1764630580.xml · derivative · entry 3 Azoy Alexander · CIK 0001771961 · Chief Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 9,500 Underlying: Common Stock · 1,900 shares Expires 2035-01-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · derivative.exercise_date: The option becomes exercisable in 48 equal monthly installments after January 1, 2025, subject to the Reporting Person's continued service to the Company. Read SEC document |
| November 26, 2025 Filed Dec 1, 2025 23:09 UTC |
Azoy AlexanderChief Accounting Officer
|
SaleCommon Stock | 1,900 | $26.00 | $49,400.00 |
DisclosureSEC source: 0001771961-25-000009 · wk-form4_1764630580.xml · nonDerivative · entry 2 Azoy Alexander · CIK 0001771961 · Chief Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 27,363 F1 · shares: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| November 26, 2025 Filed Dec 1, 2025 23:09 UTC |
Azoy AlexanderChief Accounting Officer
|
Exercise / conversionCommon Stock | 1,900 | $13.33 | $25,327.00 |
DisclosureSEC source: 0001771961-25-000009 · wk-form4_1764630580.xml · nonDerivative · entry 1 Azoy Alexander · CIK 0001771961 · Chief Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 29,263 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| November 18, 2025 Filed Nov 19, 2025 21:39 UTC |
Jaen Juan C.President
|
SaleCommon Stock | 5,050 | $19.75 | $99,737.50 |
DisclosureSEC source: 0001422996-25-000009 · wk-form4_1763588347.xml · nonDerivative · entry 3 Jaen Juan C. · CIK 0001422996 · President 10b5-1 filing: Plan reported Ownership: Indirect · By Trust Disclosed balance after: 1,037,060 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 8, 2025. F4 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.48 to $20.17, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| November 17, 2025 Filed Nov 19, 2025 21:39 UTC |
Jaen Juan C.President
|
SaleCommon Stock | 7,836 | $20.71 | $162,307.07 |
DisclosureSEC source: 0001422996-25-000009 · wk-form4_1763588347.xml · nonDerivative · entry 2 Jaen Juan C. · CIK 0001422996 · President 10b5-1 filing: Plan reported Ownership: Indirect · By Trust Disclosed balance after: 1,042,110 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 8, 2025. F3 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.65 to $20.82, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| November 17, 2025 Filed Nov 19, 2025 21:39 UTC |
Jaen Juan C.President
|
SaleCommon Stock | 37,114 | $20.23 | $750,719.72 |
DisclosureSEC source: 0001422996-25-000009 · wk-form4_1763588347.xml · nonDerivative · entry 1 Jaen Juan C. · CIK 0001422996 · President 10b5-1 filing: Plan reported Ownership: Indirect · By Trust Disclosed balance after: 1,049,946 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 8, 2025. F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.65 to $20.645, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| November 07, 2025 Filed Nov 12, 2025 21:04 UTC |
Jarrett JenniferChief Operating Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 50,291 | $1.23 Strike: $1.23 | $61,737.23 |
DisclosureSEC source: 0001671311-25-000005 · wk-form4_1762981456.xml · derivative · entry 3 Jarrett Jennifer · CIK 0001671311 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 80,583 Underlying: Common Stock · 50,291 shares Expires 2027-03-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · derivative.exercise_date: The option is fully vested and currently exercisable. Read SEC document |
| November 07, 2025 Filed Nov 12, 2025 21:04 UTC |
Jarrett JenniferChief Operating Officer
|
SaleCommon Stock | 50,291 | $18.97 | $954,065.53 |
DisclosureSEC source: 0001671311-25-000005 · wk-form4_1762981456.xml · nonDerivative · entry 2 Jarrett Jennifer · CIK 0001671311 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 214,232 F1 · shares: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.59 to $19.42, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| November 07, 2025 Filed Nov 12, 2025 21:04 UTC |
Jarrett JenniferChief Operating Officer
|
Exercise / conversionCommon Stock | 50,291 | $1.23 | $61,737.23 |
DisclosureSEC source: 0001671311-25-000005 · wk-form4_1762981456.xml · nonDerivative · entry 1 Jarrett Jennifer · CIK 0001671311 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 264,523 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| October 30, 2025 Filed Nov 3, 2025 21:46 UTC |
Jaen Juan C.President
|
SaleCommon Stock | 4,314 | $20.32 | $87,649.70 |
DisclosureSEC source: 0001422996-25-000007 · wk-form4_1762206359.xml · nonDerivative · entry 1 Jaen Juan C. · CIK 0001422996 · President 10b5-1 filing: Plan reported Ownership: Indirect · By Trust Disclosed balance after: 1,087,060 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 12, 2024. F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.12 to $20.63, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| October 29, 2025 Filed Oct 30, 2025 12:49 UTC |
Jaen Juan C.President
|
SaleCommon Stock | 800 | $22.04 | $17,635.28 |
DisclosureSEC source: 0001422996-25-000005 · wk-form4_1761828546.xml · nonDerivative · entry 4 Jaen Juan C. · CIK 0001422996 · President 10b5-1 filing: Plan reported Ownership: Indirect · By Trust Disclosed balance after: 1,091,374 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 12, 2024. F5 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.035 to $22.055, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| October 29, 2025 Filed Oct 30, 2025 12:49 UTC |
Jaen Juan C.President
|
SaleCommon Stock | 29,365 | $21.53 | $632,166.78 |
DisclosureSEC source: 0001422996-25-000005 · wk-form4_1761828546.xml · nonDerivative · entry 3 Jaen Juan C. · CIK 0001422996 · President 10b5-1 filing: Plan reported Ownership: Indirect · By Trust Disclosed balance after: 1,092,174 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 12, 2024. F4 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.02 to $22.01, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| October 29, 2025 Filed Oct 30, 2025 12:49 UTC |
Jaen Juan C.President
|
SaleCommon Stock | 47,675 | $20.49 | $976,832.15 |
DisclosureSEC source: 0001422996-25-000005 · wk-form4_1761828546.xml · nonDerivative · entry 2 Jaen Juan C. · CIK 0001422996 · President 10b5-1 filing: Plan reported Ownership: Indirect · By Trust Disclosed balance after: 1,121,539 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 12, 2024. F3 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.99, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| October 28, 2025 Filed Oct 29, 2025 12:54 UTC |
Goeltz II Robert C.Chief Financial Officer
|
SaleCommon Stock | 5,000 | $20.00 | $100,000.00 |
DisclosureSEC source: 0001653881-25-000005 · wk-form4_1761742455.xml · nonDerivative · entry 1 Goeltz II Robert C. · CIK 0001653881 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 92,138 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 7, 2023. Read SEC document |
| October 28, 2025 Filed Oct 30, 2025 12:49 UTC |
Jaen Juan C.President
|
SaleCommon Stock | 19,019 | $20.19 | $383,944.16 |
DisclosureSEC source: 0001422996-25-000005 · wk-form4_1761828546.xml · nonDerivative · entry 1 Jaen Juan C. · CIK 0001422996 · President 10b5-1 filing: Plan reported Ownership: Indirect · By Trust Disclosed balance after: 1,169,214 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 12, 2024. F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.36, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| October 08, 2025 Filed Oct 8, 2025 23:08 UTC |
Jarrett JenniferChief Operating Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 37,792 | $0.00 Strike: $1.23 | $0.00 |
DisclosureSEC source: 0001671311-25-000003 · wk-form4_1759964895.xml · derivative · entry 6 Jarrett Jennifer · CIK 0001671311 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 130,874 Underlying: Common Stock · 37,792 shares Expires 2027-03-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F5 · derivative.exercise_date: The option is fully vested and currently exercisable. Read SEC document |
| October 08, 2025 Filed Oct 8, 2025 23:08 UTC |
Jarrett JenniferChief Operating Officer
|
SaleCommon Stock | 37,792 | $15.05 | $568,610.87 |
DisclosureSEC source: 0001671311-25-000003 · wk-form4_1759964895.xml · nonDerivative · entry 4 Jarrett Jennifer · CIK 0001671311 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 214,232 F1 · shares: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F4 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.00 to $15.16, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F2 · balance_after: Includes 863 shares purchased on 5/30/2025 through the Company's Employee Stock Purchase Plan. Read SEC document |
| October 08, 2025 Filed Oct 8, 2025 23:08 UTC |
Jarrett JenniferChief Operating Officer
|
Exercise / conversionCommon Stock | 37,792 | $1.23 | $46,393.46 |
DisclosureSEC source: 0001671311-25-000003 · wk-form4_1759964895.xml · nonDerivative · entry 3 Jarrett Jennifer · CIK 0001671311 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 252,024 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · balance_after: Includes 863 shares purchased on 5/30/2025 through the Company's Employee Stock Purchase Plan. Read SEC document |
| October 06, 2025 Filed Oct 8, 2025 23:08 UTC |
Jarrett JenniferChief Operating Officer
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 12,500 | $0.00 Strike: $1.23 | $0.00 |
DisclosureSEC source: 0001671311-25-000003 · wk-form4_1759964895.xml · derivative · entry 5 Jarrett Jennifer · CIK 0001671311 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 168,666 Underlying: Common Stock · 12,500 shares Expires 2027-03-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F5 · derivative.exercise_date: The option is fully vested and currently exercisable. Read SEC document |
| October 06, 2025 Filed Oct 8, 2025 23:08 UTC |
Jarrett JenniferChief Operating Officer
|
SaleCommon Stock | 12,500 | $14.54 | $181,801.25 |
DisclosureSEC source: 0001671311-25-000003 · wk-form4_1759964895.xml · nonDerivative · entry 2 Jarrett Jennifer · CIK 0001671311 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 214,232 F1 · shares: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.40 to $14.72, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F2 · balance_after: Includes 863 shares purchased on 5/30/2025 through the Company's Employee Stock Purchase Plan. Read SEC document |
| October 06, 2025 Filed Oct 8, 2025 23:08 UTC |
Jarrett JenniferChief Operating Officer
|
Exercise / conversionCommon Stock | 12,500 | $1.23 | $15,345.00 |
DisclosureSEC source: 0001671311-25-000003 · wk-form4_1759964895.xml · nonDerivative · entry 1 Jarrett Jennifer · CIK 0001671311 · Chief Operating Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 226,732 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · balance_after: Includes 863 shares purchased on 5/30/2025 through the Company's Employee Stock Purchase Plan. Read SEC document |
| September 29, 2025 Filed Sep 30, 2025 22:59 UTC |
Azoy AlexanderChief Accounting Officer
|
SaleCommon Stock | 2,831 | $13.00 | $36,803.00 |
DisclosureSEC source: 0001771961-25-000006 · wk-form4_1759273140.xml · nonDerivative · entry 1 Azoy Alexander · CIK 0001771961 · Chief Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 27,363 F1 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 6, 2025. Read SEC document |
| September 05, 2025 Filed Sep 5, 2025 23:48 UTC |
Azoy AlexanderChief Accounting Officer
|
SaleCommon Stock | 1,579 | $11.88 | $18,758.05 |
DisclosureSEC source: 0001771961-25-000003 · wk-form4_1757116088.xml · nonDerivative · entry 1 Azoy Alexander · CIK 0001771961 · Chief Accounting Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 30,194 F1 · shares: Consists of 1,579 shares purchased on 5/30/2025 through the Company's Employee Stock Purchase Plan. F2 · shares: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 6, 2025. F3 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.55 to $12.22, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| June 10, 2025 Filed Jun 12, 2025 20:29 UTC |
PERLMAN ANDREW JDirector
|
GrantStock Option (Right to Buy) · Derivative | 38,300 | $0.00 Strike: $10.02 | $0.00 |
DisclosureSEC source: 0001724521-25-000092 · wk-form4_1749760139.xml · derivative · entry 2 PERLMAN ANDREW J · CIK 0001201617 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,300 Underlying: Common Stock · 38,300 shares Expires 2035-06-09 F2 · derivative.exercise_date: The option will vest in full on the earlier of June 10, 2026 or the next annual meeting of stockholders of the issuer. The option will become fully vested and exercisable in the event the Company is subject to a change in control. Read SEC document |
| June 10, 2025 Filed Jun 12, 2025 20:29 UTC |
PERLMAN ANDREW JDirector
|
GrantCommon Stock | 13,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001724521-25-000092 · wk-form4_1749760139.xml · nonDerivative · entry 1 PERLMAN ANDREW J · CIK 0001201617 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,625 F1 · shares: Represents the grant of restricted stock units that vest in full on the earlier of June 10, 2026 or the next annual meeting of stockholders of the issuer. The RSUs will become fully vested in the event the Company is subject to a change in control. Read SEC document |
| June 10, 2025 Filed Jun 12, 2025 20:28 UTC |
FALBERG KATHRYN EDirector
|
GrantStock Option (Rights to Buy) · Derivative | 38,300 | $0.00 Strike: $10.02 | $0.00 |
DisclosureSEC source: 0001724521-25-000091 · wk-form4_1749760129.xml · derivative · entry 3 FALBERG KATHRYN E · CIK 0001206977 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,300 Underlying: Common Stock · 38,300 shares Expires 2035-06-09 F2 · derivative.exercise_date: The option will vest in full on the earlier of June 10, 2026 or the next annual meeting of stockholders of the issuer. The option will become fully vested and exercisable in the event the Company is subject to a change in control. Read SEC document |
| June 10, 2025 Filed Jun 12, 2025 20:28 UTC |
FALBERG KATHRYN EDirector
|
GrantCommon Stock | 13,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001724521-25-000091 · wk-form4_1749760129.xml · nonDerivative · entry 1 FALBERG KATHRYN E · CIK 0001206977 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,600 F1 · shares: Represents the grant of restricted stock units that vest in full on the earlier of June 10, 2026 or the next annual meeting of stockholders of the issuer. The RSUs will become fully vested in the event the Company is subject to a change in control. Read SEC document |
| June 10, 2025 Filed Jun 12, 2025 20:28 UTC |
Machado PatrickDirector
|
GrantStock Option (Right to Buy) · Derivative | 38,300 | $0.00 Strike: $10.02 | $0.00 |
DisclosureSEC source: 0001724521-25-000090 · wk-form4_1749760118.xml · derivative · entry 2 Machado Patrick · CIK 0001311210 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,300 Underlying: Common Stock · 38,300 shares Expires 2035-06-09 F2 · derivative.exercise_date: The option will vest in full on the earlier of June 10, 2026 or the next annual meeting of stockholders of the issuer. The option will become fully vested and exercisable in the event the Company is subject to a change in control. Read SEC document |
| June 10, 2025 Filed Jun 12, 2025 20:28 UTC |
Machado PatrickDirector
|
GrantCommon Stock | 13,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001724521-25-000090 · wk-form4_1749760118.xml · nonDerivative · entry 1 Machado Patrick · CIK 0001311210 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,600 F1 · shares: Represents the grant of restricted stock units that vest in full on the earlier of June 10, 2026 or the next annual meeting of stockholders of the issuer. The RSUs will become fully vested in the event the Company is subject to a change in control. Read SEC document |
| June 10, 2025 Filed Jun 12, 2025 20:28 UTC |
Ribas AntoniDirector
|
GrantStock Option (Right to Buy) · Derivative | 38,300 | $0.00 Strike: $10.02 | $0.00 |
DisclosureSEC source: 0001724521-25-000089 · wk-form4_1749760105.xml · derivative · entry 3 Ribas Antoni · CIK 0001792164 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,300 Underlying: Common Stock · 38,300 shares Expires 2035-06-09 F2 · derivative.exercise_date: The option will vest in full on the earlier of June 10, 2026 or the next annual meeting of stockholders of the issuer. The option will become fully vested and exercisable in the event the Company is subject to a change in control. Read SEC document |
| June 10, 2025 Filed Jun 12, 2025 20:28 UTC |
Ribas AntoniDirector
|
GrantCommon Stock | 13,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001724521-25-000089 · wk-form4_1749760105.xml · nonDerivative · entry 1 Ribas Antoni · CIK 0001792164 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,650 F1 · shares: Represents the grant of restricted stock units that vest in full on the earlier of June 10, 2026 or the next annual meeting of stockholders of the issuer. The RSUs will become fully vested in the event the Company is subject to a change in control. Read SEC document |
| June 10, 2025 Filed Jun 12, 2025 20:28 UTC |
Lacey David L.Director
|
GrantStock Option (Right to Buy) · Derivative | 38,300 | $0.00 Strike: $10.02 | $0.00 |
DisclosureSEC source: 0001724521-25-000088 · wk-form4_1749760091.xml · derivative · entry 2 Lacey David L. · CIK 0001734422 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,300 Underlying: Common Stock · 38,300 shares Expires 2035-06-09 F2 · derivative.exercise_date: The option will vest in full on the earlier of June 10, 2026 or the next annual meeting of stockholders of the issuer. The option will become fully vested and exercisable in the event the Company is subject to a change in control. Read SEC document |
| June 10, 2025 Filed Jun 12, 2025 20:28 UTC |
Lacey David L.Director
|
GrantCommon Stock | 13,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001724521-25-000088 · wk-form4_1749760091.xml · nonDerivative · entry 1 Lacey David L. · CIK 0001734422 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,952 F1 · shares: Represents the grant of restricted stock units that vest in full on the earlier of June 10, 2026 or the next annual meeting of stockholders of the issuer. The RSUs will become fully vested in the event the Company is subject to a change in control. Read SEC document |
| June 10, 2025 Filed Jun 12, 2025 20:27 UTC |
Lambert NicoleDirector
|
GrantStock Option (Right to Buy) · Derivative | 38,300 | $0.00 Strike: $10.02 | $0.00 |
DisclosureSEC source: 0001724521-25-000086 · wk-form4_1749760070.xml · derivative · entry 2 Lambert Nicole · CIK 0001770252 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,300 Underlying: Common Stock · 38,300 shares Expires 2035-06-09 F2 · derivative.exercise_date: The option will vest in full on the earlier of June 10, 2026 or the next annual meeting of stockholders of the issuer. The option will become fully vested and exercisable in the event the Company is subject to a change in control. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.